McGrattan, K., Shell, R., Hurst-Davis, R., Young, S. D., O'Brien, E., Lavrov, A., . . . Darras, B. (2022). FP.23 Bulbar function for patients with spinal muscular atrophy type 1 following onasemnogene abeparvovec. Neuromuscular Disorders, 32, S85. https://doi.org/10.1016/j.nmd.2022.07.182
Chicago Style (17th ed.) CitationMcGrattan, K., et al. "FP.23 Bulbar Function for Patients with Spinal Muscular Atrophy Type 1 Following Onasemnogene Abeparvovec." Neuromuscular Disorders 32 (2022): S85. https://doi.org/10.1016/j.nmd.2022.07.182.
MLA (9th ed.) CitationMcGrattan, K., et al. "FP.23 Bulbar Function for Patients with Spinal Muscular Atrophy Type 1 Following Onasemnogene Abeparvovec." Neuromuscular Disorders, vol. 32, 2022, p. S85, https://doi.org/10.1016/j.nmd.2022.07.182.